Lon R White1, Steven D Edland2, Laura S Hemmy2, Kathleen S Montine2, Chris Zarow2, Joshua A Sonnen2, Jane H Uyehara-Lock2, Rebecca P Gelber2, G Webster Ross2, Helen Petrovitch2, Kamal H Masaki2, Kelvin O Lim2, Lenore J Launer2, Thomas J Montine2. 1. From the Pacific Health Research and Education Institute (L.R.W., R.P.G., G.W.R., H.P.); Departments of Geriatric Medicine (L.R.W., H.P., K.H.M.), Pathology (J.H.U.-L.), and Medicine (G.W.R., H.P.), University of Hawaii John A. Burns School of Medicine, Honolulu; Laboratory of Epidemiology and Population Sciences Intramural Research Program (L.R.W., L.J.L.), National Institute on Aging, NIH, Bethesda, MD; Departments of Family Preventive Medicine (S.D.E.) and Neurosciences (S.D.E.), University of California San Diego, La Jolla; Department of Psychiatry (L.S.H., K.O.L.), University of Minnesota, Minneapolis; Geriatric Research, Education, and Clinical Center (L.R.W., L.S.H., K.O.L.), VA Medical Center, Minneapolis, MN; Department of Pathology (K.S.M., T.J.M.), University of Washington, Seattle; Department of Neurology (C.Z.), Keck School of Medicine, University of Southern California, Los Angeles; Department of Pathology (J.A.S.), University of Utah, Salt Lake City; VA Pacific Islands Health Care System (R.P.G., G.W.R., H.P.); and Kuakini Medical Center (K.H.M.), Honolulu, HI. lon@hawaii.edu. 2. From the Pacific Health Research and Education Institute (L.R.W., R.P.G., G.W.R., H.P.); Departments of Geriatric Medicine (L.R.W., H.P., K.H.M.), Pathology (J.H.U.-L.), and Medicine (G.W.R., H.P.), University of Hawaii John A. Burns School of Medicine, Honolulu; Laboratory of Epidemiology and Population Sciences Intramural Research Program (L.R.W., L.J.L.), National Institute on Aging, NIH, Bethesda, MD; Departments of Family Preventive Medicine (S.D.E.) and Neurosciences (S.D.E.), University of California San Diego, La Jolla; Department of Psychiatry (L.S.H., K.O.L.), University of Minnesota, Minneapolis; Geriatric Research, Education, and Clinical Center (L.R.W., L.S.H., K.O.L.), VA Medical Center, Minneapolis, MN; Department of Pathology (K.S.M., T.J.M.), University of Washington, Seattle; Department of Neurology (C.Z.), Keck School of Medicine, University of Southern California, Los Angeles; Department of Pathology (J.A.S.), University of Utah, Salt Lake City; VA Pacific Islands Health Care System (R.P.G., G.W.R., H.P.); and Kuakini Medical Center (K.H.M.), Honolulu, HI.
Abstract
OBJECTIVE: To examine frequencies and relationships of 5 common neuropathologic abnormalities identified at autopsy with late-life cognitive impairment and dementia in 2 different autopsy panels. METHODS: The Nun Study (NS) and the Honolulu-Asia Aging Study (HAAS) are population-based investigations of brain aging that included repeated cognitive assessments and comprehensive brain autopsies. The neuropathologic abnormalities assessed were Alzheimer disease (AD) neuropathologic changes, neocortical Lewy bodies (LBs), hippocampal sclerosis, microinfarcts, and low brain weight. Associations with screening tests for cognitive impairment were examined. RESULTS: Neuropathologic abnormalities occurred at levels ranging from 9.7% to 43%, and were independently associated with cognitive impairment in both studies. Neocortical LBs and AD changes were more frequent among the predominantly Caucasian NS women, while microinfarcts were more common in the Japanese American HAAS men. Comorbidity was usual and very strongly associated with cognitive impairment. Apparent cognitive resilience (no cognitive impairment despite Braak stage V) was strongly associated with minimal or no comorbid abnormalities, with fewer neocortical AD lesions, and weakly with longer interval between final testing and autopsy. CONCLUSIONS: Total burden of comorbid neuropathologic abnormalities, rather than any single lesion type, was the most relevant determinant of cognitive impairment in both cohorts, often despite clinical diagnosis of only AD. These findings emphasize challenges to dementia pathogenesis and intervention research and to accurate diagnoses during life.
OBJECTIVE: To examine frequencies and relationships of 5 common neuropathologic abnormalities identified at autopsy with late-life cognitive impairment and dementia in 2 different autopsy panels. METHODS: The Nun Study (NS) and the Honolulu-Asia Aging Study (HAAS) are population-based investigations of brain aging that included repeated cognitive assessments and comprehensive brain autopsies. The neuropathologic abnormalities assessed were Alzheimer disease (AD) neuropathologic changes, neocortical Lewy bodies (LBs), hippocampal sclerosis, microinfarcts, and low brain weight. Associations with screening tests for cognitive impairment were examined. RESULTS:Neuropathologic abnormalities occurred at levels ranging from 9.7% to 43%, and were independently associated with cognitive impairment in both studies. Neocortical LBs and AD changes were more frequent among the predominantly Caucasian NS women, while microinfarcts were more common in the Japanese American HAAS men. Comorbidity was usual and very strongly associated with cognitive impairment. Apparent cognitive resilience (no cognitive impairment despite Braak stage V) was strongly associated with minimal or no comorbid abnormalities, with fewer neocortical AD lesions, and weakly with longer interval between final testing and autopsy. CONCLUSIONS: Total burden of comorbid neuropathologic abnormalities, rather than any single lesion type, was the most relevant determinant of cognitive impairment in both cohorts, often despite clinical diagnosis of only AD. These findings emphasize challenges to dementia pathogenesis and intervention research and to accurate diagnoses during life.
Authors: Carol Brayne; Kathryn Richardson; Fiona E Matthews; Jane Fleming; Sally Hunter; John H Xuereb; Eugene Paykel; Elizabeta B Mukaetova-Ladinska; Felicia A Huppert; Angela O'Sullivan; Tom Dening Journal: J Alzheimers Dis Date: 2009 Impact factor: 4.472
Authors: Lon White; Helen Petrovitch; John Hardman; James Nelson; Daron G Davis; G Webster Ross; Kamal Masaki; Lenore Launer; William R Markesbery Journal: Ann N Y Acad Sci Date: 2002-11 Impact factor: 5.691
Authors: Joshua A Sonnen; Karen Santa Cruz; Laura S Hemmy; Randall Woltjer; James B Leverenz; Kathleen S Montine; Clifford R Jack; Jeffrey Kaye; Kelvin Lim; Eric B Larson; Lon White; Thomas J Montine Journal: Arch Neurol Date: 2011-08
Authors: Rebecca P Gelber; Helen Petrovitch; Kamal H Masaki; Robert D Abbott; George Webster Ross; Lenore J Launer; Lon R White Journal: J Am Geriatr Soc Date: 2011-12-28 Impact factor: 5.562
Authors: W T Longstreth; Joshua A Sonnen; Thomas D Koepsell; Walter A Kukull; Eric B Larson; Thomas J Montine Journal: Alzheimer Dis Assoc Disord Date: 2009 Jul-Sep Impact factor: 2.703
Authors: Willa D Brenowitz; Sarah E Monsell; Frederick A Schmitt; Walter A Kukull; Peter T Nelson Journal: J Alzheimers Dis Date: 2014 Impact factor: 4.472
Authors: Andrea R Zammit; Charles B Hall; Richard B Lipton; Mindy J Katz; Graciela Muniz-Terrera Journal: J Int Neuropsychol Soc Date: 2018-01-10 Impact factor: 2.892
Authors: Lei Yu; Robert J Dawe; Patricia A Boyle; Chris Gaiteri; Jingyun Yang; Aron S Buchman; Julie A Schneider; Konstantinos Arfanakis; Philip L De Jager; David A Bennett Journal: JAMA Neurol Date: 2017-12-01 Impact factor: 18.302
Authors: Marina Buciuc; Jennifer L Whitwell; Bradley F Boeve; Tanis J Ferman; Jonathan Graff-Radford; Rodolfo Savica; Kejal Kantarci; Julie A Fields; David S Knopman; Ronald C Petersen; Joseph E Parisi; Melissa E Murray; Dennis W Dickson; Keith A Josephs Journal: J Neurol Date: 2020-01-31 Impact factor: 4.849
Authors: Melinda C Power; Elizabeth Mormino; Anja Soldan; Bryan D James; Lei Yu; Nicole M Armstrong; Katherine J Bangen; Lisa Delano-Wood; Melissa Lamar; Yen Ying Lim; Kelly Nudelman; Laura Zahodne; Alden L Gross; Dan Mungas; Keith F Widaman; Julie Schneider Journal: Ann Neurol Date: 2018-06-26 Impact factor: 10.422
Authors: John L Robinson; Edward B Lee; Sharon X Xie; Lior Rennert; EunRan Suh; Colin Bredenberg; Carrie Caswell; Vivianna M Van Deerlin; Ning Yan; Ahmed Yousef; Howard I Hurtig; Andrew Siderowf; Murray Grossman; Corey T McMillan; Bruce Miller; John E Duda; David J Irwin; David Wolk; Lauren Elman; Leo McCluskey; Alice Chen-Plotkin; Daniel Weintraub; Steven E Arnold; Johannes Brettschneider; Virginia M-Y Lee; John Q Trojanowski Journal: Brain Date: 2018-07-01 Impact factor: 13.501
Authors: Lei Yu; Robert J Dawe; Aron S Buchman; Patricia A Boyle; Julie A Schneider; Konstantinos Arfanakis; David A Bennett Journal: Behav Brain Res Date: 2016-09-03 Impact factor: 3.332
Authors: Margaret E Flanagan; Brenna Cholerton; Caitlin S Latimer; Laura S Hemmy; Steven D Edland; Kathleen S Montine; Lon R White; Thomas J Montine Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472